Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer
Clinical trial NCT04856475 · WITHDRAWN
Trial details
- NCT number
- NCT04856475
- Sponsor
- Jules Bordet Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2021-11-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.